ロード中...
Retreatment with carboplatin and paclitaxel for recurrent endometrial cancer: A retrospective study of the Memorial Sloan Kettering Cancer Center experience
Women with endometrial cancer (EC) frequently receive adjuvant paclitaxel and carboplatin (PC) chemotherapy. There is no standard first line chemotherapy at disease recurrence. Data extrapolated from ovarian cancer has suggested that patients with recurrent EC may benefit from further platinum-based...
保存先:
| 出版年: | Gynecol Oncol Rep |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6461565/ https://ncbi.nlm.nih.gov/pubmed/31011610 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gore.2019.04.002 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|